Platinum-based chemotherapeutics are a cornerstone in
the treatment
of many malignancies. However, their dose-limiting side effects have
rooted efforts to develop new drug candidates with higher selectivity
for tumor tissues and less problematic side effects. Here, we developed
a cytotoxic platinum(II) complex based on Zeise’s salt, containing
the nonsteroidal anti-inflammatory drug acetylsalicylic acid and alanine
as ligands (4). The previously developed complex (5) displayed high reactivity against sulfur-containing biomolecules;
therefore, we put the focus on the optimization of the structure regarding
its stability. Different amino acids were used as biocompatible chelating
ligands to achieve this aim. Differences in the coordination sphere
caused pronounced changes in the stability of Zeise-type precursors 1–3. Coordination with l-Ala through N in
the trans position to ethylene showed the most promising
results and was employed to stabilize 5. As a result,
complex 4 showed improved stability and cytotoxicity,
outperforming both 5 and 1.